**Core Concept**
Amylin is a hormone co-secreted with insulin from the pancreas, playing a crucial role in glucose regulation. It inhibits glucagon secretion, reduces postprandial glucagon levels, and slows gastric emptying, which helps control postprandial glucose levels.

**Why the Correct Answer is Right**
The analogue of Amylin, Pramlintide, works by mimicking the action of naturally occurring Amylin. It inhibits glucagon secretion, reduces postprandial glucagon levels, and slows gastric emptying, thereby helping to control postprandial glucose levels. Pramlintide is administered via subcutaneous injection before meals and is used as an adjunct to insulin therapy in patients with type 1 and type 2 diabetes.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not correspond to any known Amylin analogue approved for diabetes treatment.
**Option B:** This option is incorrect as it does not accurately describe any known Amylin analogue approved for diabetes treatment.
**Option C:** This option is incorrect as it does not correspond to any known Amylin analogue approved for diabetes treatment.

**Clinical Pearl / High-Yield Fact**
Pramlintide is often administered via subcutaneous injection before meals to help control postprandial glucose levels in patients with type 1 and type 2 diabetes.

**Correct Answer: C. Pramlintide**